Connect MDS and AML: The myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) disease registry.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: David P. Steensma, Mehrdad Abedi, Eyal C. Attar, Rafael Bejar, Christopher R. Cogle, Guillermo Garcia-Manero, David L. Grinblatt, Xiaomei Ma, Jaroslaw P. Maciejewski, Daniel Aaron Pollyea, Gail J. Roboz, Michael Savona, Bart L. Scott, Mikkael A. Sekeres, Michael A. Thompson, Oleg Zernovak, Mary M. Sugrue, Arlene S. Swern, Melissa Nifenecker, Harry Paul Erba
Institutions: Dana-Farber Cancer Institute, UC Davis Comprehensive Cancer Center, University of California, Davis, Harvard University, Massachusetts General Hospital, Moores Cancer Center, University of Florida, The University of Texas MD Anderson Cancer Center, Endeavor Health, Yale University, Cleveland Clinic, University of Colorado Cancer Center, NewYork–Presbyterian Hospital, Tennessee Oncology, Fred Hutch Cancer Center, Aurora Health Care, Celgene (United States), University of Alabama at Birmingham
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3021103590